Member Login
  1. Stocks
    2. /
  2. Moderna (NASDAQ: MRNA)
    3. /

NASDAQ:MRNA (Moderna)

About MRNA

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

  • Should you invest $1,000 in Moderna right now?

    Before you buy stock in Moderna, consider this:

    The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Moderna wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

    Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

    Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

    See the Top Stocks * Returns as of 3/20/25

    • Moderna (NASDAQ: MRNA) Latest News

    Investing

    4 of the Top-Growing Stocks on Earth

    | Amy Legate-Wolfe

    These 4 growth stocks have been some of the biggest and best performers in the world over the last three…

    Read more »

    Tech Stocks

    Why Shopify Stock’s Steep Upside Might Be Over

    | Victoria Hetherington

    Looking for a stock to trim this fall? Consider selling shares in Shopify (TSX:SHOP)(NYSE:SHOP) if you’re bullish on a vaccine.

    Read more »

    Stocks for Beginners

    5 Top Stocks to Buy Now for a Vaccine Breakthrough

    | Victoria Hetherington

    Names such as Air Canada (TSX:AC) are key contrarian picks for recovery upside. Find out which other names are buys…

    Read more »

    Dividend Stocks

    2 Top Stocks to Watch in September

    | Victoria Hetherington

    Find out why investors should keep an eye on Rogers Communications (TSX:RCI.B)(NYSE:RCI) and one other key stock this fall.

    Read more »

    Tech Stocks

    Why Are Canadians Watching Moderna Stock Right Now?

    | Victoria Hetherington

    Canadians have been eyeing Moderna (NASDAQ:MRNA) for upside. Here’s why this name stands out in the current market.

    Read more »

    Tech Stocks

    Tech Stock Selloff: What Canadians Need to Know

    | Victoria Hetherington

    The TSX outperformed Shopify (TSX:SHOP)(NYSE:SHOP) stock last week. Here’s why it happened, and what investors should do about it.

    Read more »